Adler, G., Mueller, B., & Articus, K. (2014). The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions. Int J Clin Pract.
Chicago ZitierstilAdler, G., B. Mueller, und K. Articus. "The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients With Alzheimer's Disease Under Daily Practice Conditions." Int J Clin Pract 2014.
MLA ZitierstilAdler, G., B. Mueller, und K. Articus. "The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients With Alzheimer's Disease Under Daily Practice Conditions." Int J Clin Pract 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.